Background
Infections due to papillomaviruses are common and lead to a wide variety of clinical manifestations that involve the epidermal surfaces. Manifestations include common warts (verrucae vulgaris), palmo-plantar warts, flat warts (verrucae plana), oral warts, focal epithelia hyperplasia, epidermodysplasia verruciformis (EDV), genital warts (condyloma acuminata), Bowen papulosis, Bowen disease, papillomas of the mucosal surfaces, and intraepithelial neoplasias.
Strong evidence indicates that certain papillomaviruses are involved in cervical and genital cancers. Some have also been implicated in laryngeal/oral cancer and some lung cancers.
Genital human papillomavirus (HPV) infection is the most common sexually transmitted infection in the United States.
Plantar warts.
Flat wart. Pathophysiology
Papillomaviruses are small (55 nm) double-stranded DNA viruses. Papillomaviruses are widely disseminated in the animal kingdom, and more than 200 genotypes of HPV that infect the skin and mucosal surfaces have been characterized. These viruses are highly species-specific. Papillomaviruses have never been grown in vitro but have been characterized by molecular methods.
The genome of papillomaviruses is approximately 8000 base pairs divided into 3 major functional regions. The early (E) region codes for 6 nonstructural genes, several of which are associated with cellular transformation. The late (L) region codes for 2 structural proteins, L1 and L2, that form the capsid. The long control region is a noncoding region that regulates replication and gene function.
These viruses are classified by the molecular similarity of their genetic material and are assigned a genotype number.
The viruses infect the basal keratinocyte of the epidermis, presumably through disruptions of the skin or mucosal surface. At this location, the virus remains latent in the cell as a circular episome in low copy numbers. As the epidermal cells differentiate and migrate to the surface, the virus is triggered to undergo replication and maturation and, at the keratinic layer, the virus is present in high copy numbers and is shed in the exfoliation cells. The process of virus replication alters the character of the epidermis, resulting in cutaneous or mucosal excrescences known as warts. HPVs are broadly grouped into cutaneous and mucosal type, based on the clinical location of the lesion.
Although some overlap exists, most papillomaviruses have distinct anatomic predilections, infecting only certain epidermal sites, such as skin or genital mucosa. The virus has the potential to integrate into host DNA frequently with the loss of the early regulatory function. Numerous viral genotypes have the potential to transform cells and are associated with epidermal malignancies. This appears involve interactions of E6 and E7 proteins with host cell function. The mechanism for transformation is not known, but the viral DNA appears to integrate into the genome of the host cell.
Table 1. Association of HPV Types With Morphology and Site of Skin Lesions (Open Table in a new window)
| Lesion | Location | HPV Genotype |
| Common wart | Mostly hands | 2, 4 |
| Plantar wart | Bottom of feet | 1 |
| Mosaic wart | Hands and feet | 2 |
| Flat wart | Arms, face, knees | 3, 10, 28, 41 |
| Butcher wart | Hand | 7 |
| Extragenital Bowen disease | Upper and lower extremities, head | 2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73 |
| Macular plaques of epidermodysplasia verruciformis | Light-exposed areas | 5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50 |
Table 2. HPV Types Associated With Anogenital Lesions (Open Table in a new window)
| Lesions | HPV Genotype |
| Genital warts | 6, 11 |
| Flat condylomata | 6, 11, 16, 18, 31 |
| Cervical intraepithelial neoplasia | 16, 18, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 56 |
| Bowen disease | 6, 11 |
| Buschke-Löwenstein tumors | 6, 11 |
| Vulvar intraepithelial neoplasia | 16 (occasionally 6, 11) |
| Cervical cancer | 16, 18 (strong association) |
| 31, 33, 35, 45, 51, 52, 56 (moderate association) | |
| 6, 11, 42, 43, 44 (weak association) | |
| Penile intraepithelial neoplasia | 16, 18 |
| Anal intraepithelial neoplasia | 16 (rarely 6, 11, 18, 33) |
Epidemiology
Frequency
United States
The United States has no reporting system for HPV infections. Infections and the development of warts appear to be common throughout life. In general, in the past several decades, the prevalence of genital HPV infections is considered to have increased dramatically, and it is now one of the most common sexually transmitted diseases, with an estimated 6.2 million new infections per year. The frequency of genital infections is associated with the number of sexual partners and the age of sexual debut. In cervical neoplasias, the HPV genome can be detected in more than 95% of tumors.
Using data and self-collected cervicovaginal specimens from 4150 females, from consecutive National Health and Nutrition Examination Surveys (2003–2006), Hariri et al found HPV present in 42.5% of US females aged 14-59 years. The highest rate of infection is among young females aged 20-24 years.[1]
Mortality/Morbidity
Most common warts are of cosmetic concern and generally cause little problem unless their anatomic location induces mechanical problems. For example, plantar warts can disrupt ambulation because of their location. Laryngeal papillomas may disrupt breathing or speaking. Genital warts occasionally cause problems such as urethral obstruction. Condyloma acuminata can become extremely large, resulting in tissue breakdown or secondary infection. In the context of immune deficiency, such as HIV infection, the growth of warts due to HPV can be augmented, significantly enhancing the associated anatomical problems.
Verrucous warts in a patient with HIV infection. The major morbidity and mortality related to HPV infections are due to the development of malignancies. While the vast majority of genital HPV infections resolve spontaneously, persistent infection can lead to neoplastic changes. Cervical cancer is the second most common cause of morbidity and death in women in the United States. Malignancies such as Bowen tumors may also lead to morbidity and death.
Race
HPV infections have no racial predilection.
Sex
HPV infections have no sexual predilection.
Age
People of any age may develop common warts. HPV infects more than 50% of sexually active adults. Genital infection generally occurs during the sexually active period in a person's life, and infections increase with the number of sexual partners.
Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the national health and nutrition examination survey, 2003-2006. J Infect Dis. Aug 2011;204(4):566-73. [Medline].
[Guideline] FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline]. [Full Text].
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males - Advisory Committee on Immunization Practices (ACIP), 2011. MMWR Morb Mortal Wkly Rep. Dec 23 2011;60:1705-8. [Medline].
FDA. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):626-9. [Medline].
FDA. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. May 28 2010;59(20):630-2. [Medline].
Ault KA. Human papillomavirus infections: diagnosis, treatment, and hope for a vaccine. Obstet Gynecol Clin North Am. Dec 2003;30(4):809-17. [Medline].
Beutner KR, Ferenczy A. Therapeutic approaches to genital warts. Am J Med. May 5 1997;102(5A):28-37. [Medline].
Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. Jan 2003;16(1):1-17. [Medline].
Carr J, Gyorfi T. Human papillomavirus. Epidemiology, transmission, and pathogenesis. Clin Lab Med. Jun 2000;20(2):235-55. [Medline].
Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol. Jul 2009;45 Suppl 1:S3-S12. [Medline].
Fazel N, Wilczynski S, Lowe L, Su LD. Clinical, histopathologic, and molecular aspects of cutaneous human papillomavirus infections. Dermatol Clin. Jul 1999;17(3):521-36, viii. [Medline].
Huang CM. Human papillomavirus and vaccination. Mayo Clin Proc. Jun 2008;83(6):701-6; quiz 706-7. [Medline].
Huh WK. Human papillomavirus infection: a concise review of natural history. Obstet Gynecol. Jul 2009;114(1):139-43. [Medline].
Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med. May 5 1997;102(5A):3-8. [Medline].
Sedlacek TV. Advances in the diagnosis and treatment of human papillomavirus infections. Clin Obstet Gynecol. Jun 1999;42(2):206-20. [Medline].
Siddiqui MA, Perry CM. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil). Drugs. 2006;66(9):1263-71; discussion 1272-3. [Medline].
Tjalma WA, Arbyn M, Paavonen J, van Waes TR, Bogers JJ. Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer. Int J Gynecol Cancer. Sep-Oct 2004;14(5):751-61. [Medline].
Wiley DJ, Douglas J, Beutner K, Cox T, Fife K, Moscicki AB, et al. External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis. Oct 15 2002;35(Suppl 2):S210-24. [Medline].
| Lesion | Location | HPV Genotype |
| Common wart | Mostly hands | 2, 4 |
| Plantar wart | Bottom of feet | 1 |
| Mosaic wart | Hands and feet | 2 |
| Flat wart | Arms, face, knees | 3, 10, 28, 41 |
| Butcher wart | Hand | 7 |
| Extragenital Bowen disease | Upper and lower extremities, head | 2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73 |
| Macular plaques of epidermodysplasia verruciformis | Light-exposed areas | 5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50 |
| Lesions | HPV Genotype |
| Genital warts | 6, 11 |
| Flat condylomata | 6, 11, 16, 18, 31 |
| Cervical intraepithelial neoplasia | 16, 18, 31, 33, 35, 39, 42, 43, 44, 45, 51, 52, 56 |
| Bowen disease | 6, 11 |
| Buschke-Löwenstein tumors | 6, 11 |
| Vulvar intraepithelial neoplasia | 16 (occasionally 6, 11) |
| Cervical cancer | 16, 18 (strong association) |
| 31, 33, 35, 45, 51, 52, 56 (moderate association) | |
| 6, 11, 42, 43, 44 (weak association) | |
| Penile intraepithelial neoplasia | 16, 18 |
| Anal intraepithelial neoplasia | 16 (rarely 6, 11, 18, 33) |

